tetano
Editor, Senior Moderator
Postepy Dermatol Alergol
. 2022 Jun;39(3):491-508.
doi: 10.5114/ada.2020.99294. Epub 2020 Sep 25.
Dermatological manifestations of the Coronavirus disease 2019 in children: a systemic review
Piotr Ciechanowicz[SUP] 1 [/SUP], Klaudia Dopytalska[SUP] 1 [/SUP], Michał Szczerba[SUP] 2 [/SUP], Elżbieta Szymańska[SUP] 1 [/SUP], Irena Walecka[SUP] 1 [/SUP]
Affiliations
Abstract
Introduction: An increasing number of publications describing dermatoses associated with Coronavirus disease 2019 (COVID-19) have shown differences in the morphology and incidence of dermatoses in children compared to the general population.
Material and methods: Among 22 selected full-text articles, dermatoses associated with COVID-19 have been described in 196 children (average age: 12.57 years). Dermatoses were the only symptom in most patients (n = 134; 68.4%). RT-PCR tests of nasopharyngeal swabs confirmed SARS-CoV-2 infection in only 18 cases (n = 18/69; 26.1%).
Results: Dermatoses described include chilblain-like lesions (n = 173; 88.3%), maculopapular rash (n = 16; 8.2%), erythema multiforme-like lesions (n = 12; 6.1%), varicella-like exanthema (n = 1; 0.5%), and urticaria (n = 1; 0.5%).
Conclusions: This publication aims to summarise existing data on dermatoses and to draw attention to how identification of dermatological symptoms in paediatric patients can provide a quick and reliable indicator of COVID-19.
Keywords: COVID-19; SARS-CoV-2; chilblain-like; coronavirus; paediatric; skin lesion.
. 2022 Jun;39(3):491-508.
doi: 10.5114/ada.2020.99294. Epub 2020 Sep 25.
Dermatological manifestations of the Coronavirus disease 2019 in children: a systemic review
Piotr Ciechanowicz[SUP] 1 [/SUP], Klaudia Dopytalska[SUP] 1 [/SUP], Michał Szczerba[SUP] 2 [/SUP], Elżbieta Szymańska[SUP] 1 [/SUP], Irena Walecka[SUP] 1 [/SUP]
Affiliations
- PMID: 35950134
- PMCID: PMC9326916
- DOI: 10.5114/ada.2020.99294
Abstract
Introduction: An increasing number of publications describing dermatoses associated with Coronavirus disease 2019 (COVID-19) have shown differences in the morphology and incidence of dermatoses in children compared to the general population.
Material and methods: Among 22 selected full-text articles, dermatoses associated with COVID-19 have been described in 196 children (average age: 12.57 years). Dermatoses were the only symptom in most patients (n = 134; 68.4%). RT-PCR tests of nasopharyngeal swabs confirmed SARS-CoV-2 infection in only 18 cases (n = 18/69; 26.1%).
Results: Dermatoses described include chilblain-like lesions (n = 173; 88.3%), maculopapular rash (n = 16; 8.2%), erythema multiforme-like lesions (n = 12; 6.1%), varicella-like exanthema (n = 1; 0.5%), and urticaria (n = 1; 0.5%).
Conclusions: This publication aims to summarise existing data on dermatoses and to draw attention to how identification of dermatological symptoms in paediatric patients can provide a quick and reliable indicator of COVID-19.
Keywords: COVID-19; SARS-CoV-2; chilblain-like; coronavirus; paediatric; skin lesion.